Revenue (Tables)

3 Months Ended

Mar. 31, 2026

Revenue from Contract with Customer [Abstract]

Schedule of Investment Advisory Fees and Other Revenue

The table below summarizes the Company's investment advisory fees, medical device revenues, and other revenue (in thousands):


			Successor									Predecessor
			Three Months Ended March 31, 2026									Three Months Ended March 31, 2025
Investment advisory fees			$	1,347								$	1,416
Medical device revenues			1,370									—
Other revenue			43									7
Total revenue			$	2,760								$	1,423